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Objectives: Xerostomia is a common post-radiotherapy (post-RT) complication in
nasopharyngeal carcinoma (NPC) patients. This study evaluated the relation of post-RT
parotid gland changes with the dose received.
Methods: Data from 18 NPC patients treated by radiotherapy between 1997 and 2001
were collected. Parotid gland volumes were measured and compared between their
pre-RT and post-RT CT images; both sets of CT were conducted with the same scanning
protocol. Doppler ultrasound was used to assess the haemodynamic condition of the
glands after radiotherapy. Doppler ultrasound results were compared against 18 age-
matched normal participants. A questionnaire was used to evaluate the patients’
comments of xerostomia condition. Radiotherapy treatment plans of the participants
were retrieved from the Eclipse treatment planning system from which the radiation
doses delivered to the parotid glands were estimated. The correlations of parotid gland
doses and the post-RT changes were evaluated.
Results: The post-RT parotid glands were significantly smaller (p,0.001) than the pre-
RT ones. They also demonstrated lower vascular velocity, resistive and pulsatility indices
(p,0.05) than normal participants. The degree of volume shrinkage and subjective
severity of xerostomia demonstrated dose dependence, but such dependence was not
definite in the haemodynamic changes.
Conclusion: It was possible to predict the gland volume change and subjective
severity of xerostomia based on the dose to the parotid glands for NPC patients.
However, such prediction was not effective for the vascular changes. The damage to
the gland was long lasting and had significant effects on the patients’ quality of life.
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Xerostomia is one of the commonest radiation-induced
complications in nasopharyngeal carcinoma (NPC) patients
after a radical course of radiotherapy [1, 2]. Persistent
xerostomia, which is due to the damage of the parotid
glands, causes difficulties in mastication and swallowing
and enhances the risks of dental problems; these subsequ-
ently degrade the quality of life in long-term survivors [3, 4].
With the recent advancements in radiotherapy techni-
ques such as intensity-modulated radiotherapy (IMRT),
highly conformal dose distributions are possible and the
sparing of parotid gland can be made more effective. How-
ever, conventional radiotherapy protocol for NPC is still
used in some centres, and the treatment protocol is to em-
ploy lateral opposing beams to the face and upper neck plus
an anterior beam to cover the lower neck. This inevitably
irradiates the parotid glands to a mean dose of over 45 Gy,
with the medial portion receiving as high as 60 Gy [5, 6].
Up to now, the mechanism of parotid gland damage
and saliva reduction due to radiation is largely unknown.
It is postulated that the saliva secretion of the parotid
glands is related to the changes in morphology and
vascular condition as a result of radiation therapy [7]. CT
is a useful imaging tool for monitoring the response of
radiation therapy by providing morphological informa-
tion of the head and neck structures, including the parotid
glands. For the assessment of post-radiotherapy (post-RT)
vascular changes of parotid glands, there has been a
report of dose-dependent increases in the extracellular
extravascular space (EES) and decreases in vascular
permeability using MRI [8]. However, the variation of
haemodynamics in post-RT intraparotid vessels, which is
useful for better understanding of the physiological
changes of the parotid glands, is still unclear. Doppler
ultrasonography is effective in the evaluation of the gland
haemodynamics such as the blood flow velocity and
resistive index, which are useful parameters in the
assessment of the vasculature of the parotid gland [7].
Our study hypothesised that high-dose radiation to the
parotid gland would destroy the acini and granules,
which would alter the pressure on the blood vessels and
result in changes of the blood velocity. More importantly,
there is scant information about the relationships between
these parameters with the radiation dose delivered to the
glands. The knowledge of these relationships can provide
useful references for the prediction of the severity of
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xerostomia after radiotherapy, and better understanding
of how the complication will affect the quality of life in
long-term survivors.
The objectives of this study are to assess the change of
volume, blood flow velocity and vascular resistance of the
post-RT parotid gland and evaluate their correlationswith
the radiation dose received and the subjective assessment
of the severity of xerostomia from NPC patients.
Methods and materials
18 NPC patients (11 men and 7 women, age range
41–63 years, mean age 51.0 years) treated by conven-
tional two-dimensional external beam radiotherapy
between 1997 and 2001 were recruited (patient group).
Radiotherapy consisted of two phases. Phase I treatment
started with two large lateral opposing faciocervical
fields covering the base of the skull upper cervical
lymphatics en bloc to 40 Gy. The lower neck was
irradiated with an anterior cervical field to 40 Gy.
Phase II treatment used a 3-field technique with one
anterior and 2 wedged lateral opposing facial fields for
another 28 Gy (Figure 1). The neck was treated with a
separate anterior cervical field and midline shield for
another 26 Gy. Both phases used 6 MV photons and
involved the irradiation of both parotid glands. The total
prescribed dose to the tumour was 66–68 Gy delivered in
2 Gy daily fractions. An additional parapharyngeal boost
dose (10 Gy) was given using a 6 MV photon posterior
oblique field (Figure 2) if there was parapharyngeal
extension of disease at diagnosis [9]. All patients were
treated with radiotherapy alone and completed treat-
ment for more than 3 years (3 years, n57; 4 years, n56;
7 years, n53; 8 years, n52) with no sign of recurrence at
the time of participation in the present study. In
addition, all patients did not have any known salivary
gland disease before radiotherapy.
CT scan images were used to estimate the volume of
the parotid glands. 2 sets of CT scans were performed on
the 18 participants, 1 before radiotherapy and the other 1
at about 2–3 years after radiotherapy, which was a
routine protocol for NPC patient follow-up in local
departments. Both sets of CT were performed with
contrast following the routine head and neck protocol,
with slice thickness of 3 mm at the levels covering the
parotid glands. After the retrieval of CT images from the
database, the volumes of the gland before and after
radiotherapy were generated from the Eclipse treatment
planning system (Varian Oncology Systems, Palo Alto,
CA) by delineating the parotid glands on the corre-
sponding CT slices by the same investigator. The
percentage gland volume change (dV) was used to
indicate the differences between the pre-RT and post-RT
volumes. A paired t-test was used to study the
significance of their differences. The correlation between
dV and the total mean parotid gland dose was evaluated
by the Pearson correlation test.
Ultrasound examination of the parotid glands of the
participants was performed in 2008, about 8–11 years
after completion of radiotherapy. The examinations were
carried out by the same operator, who was blinded to the
radiotherapy protocols received by the participants, with
a 12–5 MHz linear transducer (Philips HDI 5000, Bothell,
WA). For each parotid gland, the blood flow velocity
(peak systolic velocity (PSV) and end diastolic velocity
(EDV)) and vascular resistance (resistive index (RI) and
pulsatility index (PI)) were measured using the power
Doppler and spectral Doppler sonography. PSV and
EDV were indicators of blood flow velocity during the
systole and diastole phases of the cardiac cycle,
respectively, whereas RI and PI were indicators of the
pressure exerted on the blood vessels. The settings of the
power Doppler ultrasound were standardised for high
sensitivity, with a low wall filter to allow detection of
vessels with low blood flow. Pulsed repetition frequency
Figure 1. Dose distribution of the
Phase II three-field technique at the
principal plane. The entire naso-
pharynx is enclosed by the 95%
isodose level. The medial portions
of the parotid glands receive over
70% of the isodose level.
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(PRF) was 700 Hz, and medium persistence was used.
On spectral Doppler sonography, the sample volume
was standardised for 1 mm, a low wall filter was used
and the PRF was adjusted until the spectral waveforms
were demonstrated without aliasing. Angle correction
was 60u or below. Measurements were obtained at ran-
dom locations of three vessels that consistently demon-
strated three consecutive Doppler spectral waveforms
(Figure 3). For each parotid gland, the mean PSV, EDV,
RI and PI were calculated.
To evaluate changes in the haemodynamics of the
parotid gland after radiotherapy, another 18 healthy
participants (normal group), who were age (¡3 years)
and gender matched with the patients, and with no
history of salivary gland disease and radiotherapy or
surgery in the head and neck region, were also recruited.
All healthy participants received ultrasound examination
of the parotid glands according to the standardised
scanning protocol as for the patient group. This was
based on the assumption that healthy participants with
the same age and gender would demonstrate similar
haemodynamics in the parotid gland, and deviations of
the ultrasound findings in the patient group would
indicate changes due to the radiation effect. The
haemodynamic results of both patients and normal
participants were recorded and compared using a paired
t-test. The differences of PSV, EDV, RI and PI between
the participants in the patient group and the matched
normal participants (dPSV, dEDV, dRI, dPI) were
calculated by subtracting the patient group readings
from that of the normal group. Correlations between the
d-parameters and the total mean parotid gland doses
were evaluated by the Pearson correlation test. All
participants in the patient group and healthy participant
group had the study procedures explained and written
consent was obtained before the ultrasound examination.
To estimate the doses received by the parotid glands,
the participants’ localisation radiographs, treatment
plans retrieved from the Eclipse treatment planning
system (Varian Oncology Systems), treatment records
and prescriptions were collected. For each phase of
treatment (including the two phases ¡ parapharyngeal
boost), the mean doses to the parotid glands were
calculated by correlating the dose distributions with the
anatomical information in the CT images. Their esti-
mated total mean doses were calculated by conducting
plan summation of all phases of radiotherapy treatment
using the treatment planning system.
In addition, all participants of the patient group were
required to complete a structured and validated ques-
tionnaire adapted from Zimmerman et al [10]. The
questionnaire consisted of five questions and was used
to assess the condition of xerostomia by collecting the
patients’ comments on its severity in terms of its impact
on their daily life including (1) difficulty in swallowing
and mastication, (2) difficulty with speech, (3) interrup-
tion of sleep, (4) discomfort of mouth and (5) dryness of
mouth at the time of this study. A continuous scale from
0 to 10 was used to assess the severity of individual
conditions, with \0" implying the least severe condition
and \10" the most severe condition. Apart from the
individual question scores, an overall \impact factor"
Figure 2. Field orientation and
dose distribution of the posterior
oblique faciocervical field for the
boost treatment of the parapharyn-
geal region. The prescribed dose is
at the 90% isodose level, which
encompasses a considerable portion
of the parotid gland.
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(IF), which was also calculated by taking the average
scores of the five questions, was used to indicate the
patient’s subjective xerostomia severity. In addition, each
patient was also asked to give a subjective assessment on
the percentage of salivary function at the time of
assessment compared with their salivary function before
radiation treatment (residue percentage (RP)). The IF and
RP were also checked against the total mean parotid
gland doses for correlation using the Pearson correlation
test.
This study was approved by the Human Subject Ethics
Subcommittee of the Department of Health Technology
and Informatics of the Hong Kong Polytechnic
University. All participants signed a consent form prior
to the study.
Results
In addition to the routine radiotherapy course, 11 out of
the 18 patients received the parapharyngeal boost treat-
ment, which increased the dose to the ipsilateral parotid
gland. The total maximum and mean doses received by
the parotid glands ranged from 38.1 Gy to 64.4 Gy.
The post-RT parotid gland volumes in all patients were
smaller than that of the pre-RT glands. Themean percentage
Figure 3. Spectral Doppler sonogram showing the measurement of blood flow velocity (peak systolic velocity (PSV) and end
diastolic velocity (EDV)) and vascular resistance (resistive index (RI)) of a normal parotid gland. Note the average of the
measurements is obtained from three consecutive waveforms.
Figure 4. Scatter plot of the post-
radiotherapy percentage volume
reduction in parotid gland (dV)
against the total mean parotid
gland dose.
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volume difference (dV) of all the 36 parotid glands, taking
into account the left and right sides, was extremely
significant (paired t-test, p,0.001). The overall mean volume
reduction was 12.2¡7.2 cm3, which was about 35% of the
gland volume before radiotherapy. The degree of volume
reduction showed high correlations with the total mean
doses received by the parotid gland (Figure 4).
36 parotid glands from the patient group and healthy
participant group were scanned by ultrasound. In the
ultrasound examinations, the mean values of PSV, EDV,
RI and PI of normal participants were significantly
higher than that of the post-RT patients (Table 1)
(p,0.05). However, the differences in these four para-
meters between the patients and matched normal
participants did not show correlation with the total
mean dose received by the parotid glands (Figure 5a–d).
The scores for individual questions in the questionnaire
from the patient group are shown in Figure 6. The impacts
on swallowing and mastication were relatively greater,
whereas the interruption of sleep was less severe. Besides,
the overall IF of the 18 participants in the patient group
ranged from 2.18 to 6.34, with a mean value of 4.40
(a)
(c) (d)
(b)
Figure 5. (a–d) Scatter plots showing the differences of the haemodynamic parameters between participants in the patient
group and normal group against the total mean parotid gland doses: (a) dPSV (peak systolic velocity), (b) dEDV (end diastolic
velocity), (c) dRI (resistive index) and (d) dPI (pulsatility index).
Table 1. Comparison of the Doppler ultrasound study on the haemodynamic parameters of the parotid glands between the
patient group and normal group
Patient group (n536) Normal group (n536) Paired t-test p-value
Mean SD Mean SD
PSV (cm s–1) 8.14 ¡2.56 14.71 ¡6.13 0.001
EDV (cm s–1) 3.06 ¡0.96 3.92 ¡0.67 0.007
RI 0.65 ¡0.07 0.73 ¡0.09 0.003
PI 1.09 ¡0.18 1.51 ¡0.48 0.004
PSV, peak systolic velocity; EDV, end diastolic velocity; RI, resistive index; PI, pulsatility index; SD, standard deviation.
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(Table 2). The range of residue percentage (RP) was from
20.0% to 60.0%, with a mean of 39.0%. The IF showed
positive correlation with the mean parotid gland dose
(r50.614) whereas the RP showed a negative correlation
(r520.869).
Discussion
Post-RT parotid glands demonstrated loss of gland
parenchyma and acinar cell atrophy [11, 12], which was
responsible, in part, for the more heterogeneous, variable
hyperechocity that appeared in the ultrasound scan [7]
and gland volume shrinkage in CT images.
The post-RT parotid glands demonstrated an average
of 35% volume reduction compared with normal glands,
as measured from the CT images, with the differences
being extremely significant (p,0.001). More important,
the magnitude of shrinkage (dV) was associated with the
total mean doses delivered to the glands. The findings
were in line with the studies by Wang et al [13] and
Teshima et al [14], who reported that the gland volume
reductions correlated significantly with the mean dose.
This revealed the fact that a higher radiation dose to the
parotid gland would cause greater loss and atrophy of
acinar cells, which subsequently leads to shrinkage in the
gland. The atrophy of the acinar cells was also believed
to be the main cause of impaired salivary secretion
leading to xerostomia.
The Doppler results showed that radiation treatment
had an impact on the haemodynamics of the parotid
gland. The PSV, EDV, RI and PI were significantly higher
in normal glands. This implied that blood flow was faster
and there was greater pressure experienced by the
vessels in the normal glands than those of the post-RT
glands. The higher blood velocity in the normal parotid
gland was because the blood vessels of normal glands
were surrounded by the more densely packed secretory
acini and granules, which were less easy to dilate and
pulsate (similar to stiff vessels) during systole and
diastole, and therefore resulted in higher PSV and
EDV. In contrast, the post-RT parotid glands suffered
from the loss of acini and granules [11, 12, 15]. This led to
the reduction of compression pressure exerted on the
vessels by fewer acini and granules, and resulted in a
relatively lower RI and PI. In addition, it was also
speculated that the lower blood flow velocity and
vascular resistance in post-RT parotid glands was due
to their less organised vascular architecture. This
resulted in the increase in arterial venous shunting
across the capillary bed, which had less parenchymal
tissue through which to percolate. Since the patients and
normal subjects were age and gender matched, the
confounding effect of these two factors on the Doppler
findings would be considered minimal, and the differ-
ences in the blood flow velocity and vascular resistance
between the two groups were likely to be due to the
effect of radiation therapy. However, the differences in
PSV, EDV, RI and PI between the normal and post-RT
glands were not dose dependent, as their values did not
demonstrate significant correlations with the magnitude
of dose received by the glands. This could be due to the
relatively small sample size, which was a limitation of
this study. This implied that it was not easy to predict the
magnitude of vascular changes in the parotid glands
purely based on the total dose received.
The results of the questionnaires further proved that
there were subjective impacts of xerostomia on the NPC
survivors after radiotherapy. At the time of the assess-
ment, when the patients had completed their radiation
treatment for more than 3 years, the mouth dryness still
persisted and the difficulty in mastication and swallow-
ing remained the greatest problem, followed by the
difficulty with speech. This echoed the fact that the
radiation-induced gland damage was long lasting for the
dose levels experienced by the 18 subjects in this study.
The findings were in line with Nagler et al [16], who
reported that parotid glands irradiated with 60 Gy or
above would lead to permanent damage to acinar cells.
The results of this study also showed that complete
recovery of the salivary condition was not likely for these
dose levels, as all subjects expressed that their salivary
function was only about 40% of the normal state. An
important finding in the present study was that the
patients’ subjective assessment of the impact of xerosto-
mia showed some degree of dependence on the mean
dose received by the parotid glands. In addition, the
subjective recovery of the saliva function demonstrated
an inverse function with the mean dose received. Despite
Figure 6. A histogram showing the summary results from
the xerostomia questionnaire on the post-RT (radiotherapy)
patients.
Table 2. Results of the xerostomia questionnaire on the subjects of the patient group
Maximum Minimum Mean SD Correlation with mean parotid
dose (r value)
IF 6.34 2.18 4.40 ¡1.37 0.614
RP (%) 60.0 20.0 39.0 ¡11.7 20.869
IF, overall impact factor (average scores of the five questions); RP, residue percentage (the subjective assessment of the percentage
of salivary function remaining at the time of assessment compared with that before radiotherapy); SD, standard deviation.
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the fact that recovery from radiation-induced xerostomia
was dependent on a variety of factors, including the
patient’s general condition and length of time after
radiation treatment [17], the total mean dose received
proved to be influential to the patient’s quality of life in
this study.
The general results of this preliminary study indicated
that the change in volume of the parotid gland and level
of xerostomia in the survivors were dose dependent.
However, this study was only performed on patients
treated with conventional techniques, with the mean
dose levels to the parotid glands all above the tolerance
of the organ. This was the main reason all patients
showed some degree of gland damage and xerostomia.
With the evidence that the severity of some side effects is
dependent on the dose magnitude to the parotid gland,
this justifies the use of techniques such as intensity
modulated radiotherapy, which can further reduce the
dose to the parotid, as important to further minimise the
complications.
Conclusion
Radiation-induced xerostomia is a major cause of
morbidity among NPC patients after conventional radia-
tion therapy. There were definite impacts on the size
reduction and change in the blood flow of the parotid
glands due to radiation. It was possible to predict the
gland volume change and severity of xerostomia based on
the total dose received by the parotid glands. However,
such prediction was not effective for vascular changes.
The damage to the gland was long lasting and had signi-
ficant influence on the quality of life for post-RT patients.
Therefore, maintaining a low dose to the parotid gland
should be considered in radiotherapy treatment planning.
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